FSCO vs VOR
Comparison between FS Credit Opportunities Corp (FSCO, Company) and Vor Biopharma Inc (VOR, Company).
FSCO is from the Financial Services sector, while VOR is from the Healthcare sector.
FSCO vs VOR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
FSCO vs VOR - Historical Returns
Returns include dividend reinvestment.
FSCO vs VOR - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | FSCO | VOR |
|---|---|---|
| 2026 | -18.30% | +55.33% |
| 2025 | +4.79% | -41.61% |
| 2024 | +33.43% | -50.22% |
| 2023 | +38.45% | -66.72% |
| 2022 | +7.21% | -45.63% |
| 2021 | N/A | -69.01% |
FSCO vs VOR Drawdown Comparison
The maximum drawdown for FSCO was -35.45%, occurring on Mar 9, 2026. This drawdown has not yet recovered.
The maximum drawdown for VOR was -99.72%, occurring on May 9, 2025. This drawdown has not yet recovered.
The current FSCO drawdown is -28.06%. The current VOR drawdown is -98.33%.
| Rank | FSCO | VOR |
|---|---|---|
| #1 | -35.45% Aug 28, 2025 - Mar 9, 2026 | -99.72% Feb 25, 2021 - May 9, 2025 |
| #2 | -25.09% Nov 18, 2022 - Aug 17, 2023 | -16.81% Feb 16, 2021 - Feb 24, 2021 |
| #3 | -17.89% Apr 1, 2025 - May 2, 2025 | -1.99% Feb 10, 2021 - Feb 12, 2021 |
| #4 | -8.80% Jul 11, 2024 - Oct 2, 2024 | N/A |
| #5 | -6.48% Aug 25, 2023 - Sep 29, 2023 | N/A |
| #6 | -5.80% Nov 14, 2022 - Nov 17, 2022 | N/A |
| #7 | -5.13% Dec 27, 2023 - Feb 2, 2024 | N/A |
| #8 | -3.82% Nov 29, 2024 - Dec 20, 2024 | N/A |
| #9 | -3.65% Oct 11, 2023 - Nov 3, 2023 | N/A |
| #10 | -3.53% Mar 5, 2025 - Mar 20, 2025 | N/A |
| #11 | -3.48% Jan 22, 2025 - Feb 28, 2025 | N/A |
| #12 | -3.47% Feb 14, 2024 - Mar 15, 2024 | N/A |
| #13 | -3.40% Dec 1, 2023 - Dec 27, 2023 | N/A |
| #14 | -2.92% May 13, 2025 - May 29, 2025 | N/A |
| #15 | -2.90% Aug 4, 2025 - Aug 28, 2025 | N/A |
Correlation
Correlation between FSCO and VOR is -0.77 which considered as a strong negative correlation - the stocks tend to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks